Dyax Corp. (DYAX) - NASDAQ
Company Description
Dyax Corp is a biopharmaceutical company focused on Hereditary Angioedema and Other Plasma-Kallikrein-Mediated (PKM)Disorders and Licensing and Funded Research Portfolio.
Sector: Healthcare
Industry: Biotechnology
Country: United States